Philips re-aligns its ‘Lives Improved’ target with the UN 2030 Sustainable Development Agenda following the completion of its portfolio transformation

NEXT STORY
New Updates to the American Diabetes Association’s® 2019 Standards of Medical Care in Diabetes Incorporate Findings from the REDUCE-IT™ Cardiovascular Outcomes Study
PREV STORY
The results from Oasmia Pharmaceuticals first study with paclitaxel micellar in humans are published in the scientific journal ”Advances in Therapy”.
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Immunocore Appoints Nobel Laureate Professor Sir Peter J. Ratcliffe as Non-Executive Director

author_avatar
NASDAQ Market News

First Patient Enrolled in Phase II DOVACC trial of UV1 in Advanced Ovarian Cancer

author_avatar
NASDAQ Market News

Direct-to-Patient Market Worth US$67,897 Million by 2031. Visiongain Research Inc.

author_avatar
NASDAQ Market News